Greenwood Capital Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History

Greenwood Capital Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $2.69 Million - $3.42 Million	-5,629 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $38,132 - $46,074	-70 Reduced 1.23%	5,629 $3.15 Million
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $1.91 Million - $2.49 Million	-3,867 Reduced 40.42%	5,699 $3.55 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $3.22 Million - $4.73 Million	9,566 New	9,566 $4.67 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $4.24 Million - $5.86 Million	-14,138 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $355,708 - $420,228	956 Added 7.25%	14,138 $5.81 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $4.43 Million - $5.31 Million	13,182 New	13,182 $4.92 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.